Prevalence of Chlamydia trachomatis in human immunodeficiency virus-infected women in Cuba
AUTOR(ES)
Kouri, Vivian, Cartaya, Judith, Rodríguez, María E, Muné, Mayra, Soto, Yudira, Resik, Sonia, Bravo, Jose, Llop, Alina
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2002-12
RESUMO
To determine the prevalence rates and serovar distribution of Chlamydia trachomatis cervical infections in Cuban women, two different groups were selected. Group I consisted of 60 human immunodeficiency virus (HIV-1) seropositive women from different regions of Cuba and group II of 60 randomly selected women HIV seronegative and apparently healthy. C. trachomatis was detected in cervical scrapes by mean of nested polymerase chain reaction (PCR) specific for major out membrane protein. The overall prevalence rate of C. trachomatis in cervical scrapes determined by nested PCR was 10% in group I and the estimated prevalence was 6.6% for group II; 83.3% of HIV seropositive women with C. trachomatis infection reported history of pelvic inflammatory disease followed by cervicitis (50%). The control group C. trachomatis-infected women referred a history of cervicitis in 75% of cases. Other reports in the latter group included infertility and pelvic inflamatory disease in 50%. The present study is the first report of C. trachomatis prevalence in Cuba. It showed that there was not significantly difference in the prevalence rate of C. trachomatis between both groups.
Documentos Relacionados
- High Aspartyl Proteinase Production and Vaginitis in Human Immunodeficiency Virus-Infected Women
- Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women.
- Chlamydia trachomatis in human immunodeficiency virus-infected men treated at a referral hospital for sexually transmitted diseases in the Amazonas, Brazil
- High Prevalence of Human Papillomavirus (HPV) Infections and High Frequency of Multiple HPV Genotypes in Human Immunodeficiency Virus-Infected Women in Brazil
- Pharmacokinetics of Saquinavir plus Low-Dose Ritonavir in Human Immunodeficiency Virus-Infected Pregnant Women†